2,6-Dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol → HCID 68092147, compound
Reaction equation
Br[C:2]1[CH:3]=[C:4]2[C:9](=[CH:10][CH:11]=1)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]2[NH:15][C:16]1[CH:21]=[CH:20][C:19]([CH2:22][N:23]2[CH2:27][CH2:26][CH2:25][CH2:24]2)=[CH:18][CH:17]=1.[Cl:28][C:29]1[CH:34]=[C:33](B2OC(C)(C)C(C)(C)O2)[CH:32]=[C:31]([Cl:44])[C:30]=1[OH:45]>>[Cl:44][C:31]1[CH:32]=[C:33]([C:2]2[CH:3]=[C:4]3[C:9](=[CH:10][CH:11]=2)[N:8]=[CH:7][C:6]([C:12](=[O:14])[CH3:13])=[C:5]3[NH:15][C:16]2[CH:21]=[CH:20][C:19]([CH2:22][N:23]3[CH2:27][CH2:26][CH2:25][CH2:24]3)=[CH:18][CH:17]=2)[CH:34]=[C:29]([Cl:28])[C:30]=1[OH:45]Participants
3
Procedure
Following general procedure D, 1-(6-bromo-4-((4-(pyrrolidin-1-ylmethyl)phenyl)amino)quinolin-3-yl)ethanone (42.4 mg, 0.10 mmol) was reacted with 2,6-dichloro-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)phenol (38.4 mg, 0.133 mmol) to afford the desired product (28.4 mg, 56%) as a yellow solid. 1H NMR (500 MHz, MeOD) δ 9.17 (s, 1H), 8.02-7.94 (m, 2H), 7.77 (s, 1H), 7.55 (d, J=8.4 Hz, 2H), 7.32 (d, J=8.4 Hz, 2H), 7.20 (s, 2H), 4.41 (s, 2H), 3.27 (br s, 4H), 2.78 (s, 3H), 2.07 (br s, 4H). ESI MS m/z 506 [C28H25Cl2N3O2+H]+; HPLC 95.1% (AUC), tR=10.81 min.
Sources & evidence
- ORD record
- ord-bcc9439d06b84653ba494d012800c86d
- Source dataset
- uspto-grants-2015_09
- Patent number
- US09120749B2
Reaction notes
Loading…